{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T13:26:23Z","timestamp":1784813183068,"version":"3.55.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.atherosclerosis.2014.03.004","type":"journal-article","created":{"date-parts":[[2014,3,19]],"date-time":"2014-03-19T15:06:13Z","timestamp":1395241573000},"page":"237-243","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Targeted mouse complement inhibitor CR2-Crry protects against the development of atherosclerosis in mice"],"prefix":"10.1016","volume":"234","author":[{"given":"Fengming","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gongxiong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lining","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Tomlinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuebin","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2014.03.004_bib1","first-page":"429","article-title":"Accumulation of IgG and complement factor C3 in human arterial endothelium and atherosclerotic lesions","volume":"92","author":"Hansson","year":"1984","journal-title":"Acta Pathol Microbiol Immunol Scand A"},{"key":"10.1016\/j.atherosclerosis.2014.03.004_bib2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0021-9150(86)90111-5","article-title":"Immunoelectron-microscopic localization of the terminal C5b-9 complement complex in human atherosclerotic fibrous plaque","volume":"61","author":"Rus","year":"1986","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2014.03.004_bib3","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1161\/CIRCRESAHA.108.191361","article-title":"Complement regulator CD59 protects against atherosclerosis by restricting the formation of complement membrane attack complex","volume":"104","author":"Wu","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.atherosclerosis.2014.03.004_bib4","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1161\/ATVBAHA.108.169912","article-title":"Brief report: accelerated atherosclerosis in low-density lipoprotein receptor-deficient mice lacking the membrane-bound complement regulator CD59","volume":"28","author":"Yun","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2014.03.004_bib5","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.molimm.2009.10.035","article-title":"The membrane attack complex of complement drives the progression of atherosclerosis in apolipoprotein E knockout mice","volume":"47","author":"Lewis","year":"2010","journal-title":"Mol Immunol"},{"key":"10.1016\/j.atherosclerosis.2014.03.004_bib6","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1016\/j.molimm.2009.02.009","article-title":"CD59 but not DAF deficiency accelerates atherosclerosis in female ApoE knockout mice","volume":"46","author":"An","year":"2009","journal-title":"Mol Immunol"},{"key":"10.1016\/j.atherosclerosis.2014.03.004_bib7","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1096\/fj.10-174284","article-title":"Complement C5a inhibition reduces atherosclerosis in ApoE\u2212\/\u2212 mice","volume":"25","author":"Manthey","year":"2011","journal-title":"Faseb J"},{"key":"10.1016\/j.atherosclerosis.2014.03.004_bib8","first-page":"333","article-title":"The complement system in liver diseases","volume":"3","author":"Qin","year":"2006","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.atherosclerosis.2014.03.004_bib9","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1615\/CritRevImmunol.v19.i3.10","article-title":"Regulation of the complement membrane attack pathway","volume":"19","author":"Morgan","year":"1999","journal-title":"Crit Rev Immunol"},{"key":"10.1016\/j.atherosclerosis.2014.03.004_bib10","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1073\/pnas.84.7.2007","article-title":"Cloning and characterization of cDNAs encoding the complete sequence of decay-accelerating factor of human complement","volume":"84","author":"Medof","year":"1987","journal-title":"Proc Natl Acad Sci United States Am"},{"key":"10.1016\/j.atherosclerosis.2014.03.004_bib11","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1056\/NEJM198504253121704","article-title":"Deficiency of the complement regulatory protein, \"decay-accelerating factor,\" on membranes of granulocytes, monocytes, and platelets in paroxysmal nocturnal hemoglobinuria","volume":"312","author":"Nicholson-Weller","year":"1985","journal-title":"New Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2014.03.004_bib12","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1007\/s00335-001-2060-8","article-title":"Genomic structure, functional comparison, and tissue distribution of mouse Cd59a and Cd59b","volume":"12","author":"Qin","year":"2001","journal-title":"Mamm Genome"},{"key":"10.1016\/j.atherosclerosis.2014.03.004_bib13","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.4049\/jimmunol.173.6.3684","article-title":"CD59a is the primary regulator of membrane attack complex assembly in the mouse","volume":"173","author":"Baalasubramanian","year":"2004","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.atherosclerosis.2014.03.004_bib14","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.4049\/jimmunol.144.5.1988","article-title":"The murine complement receptor gene family. III. The genomic and transcriptional complexity of the Crry and Crry-ps genes","volume":"144","author":"Paul","year":"1990","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.atherosclerosis.2014.03.004_bib15","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1126\/science.287.5452.498","article-title":"A\u00a0critical role for murine complement regulator crry in fetomaternal tolerance","volume":"287","author":"Xu","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2014.03.004_bib16","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1634\/theoncologist.2008-0086","article-title":"FDA report: eculizumab (Soliris) for the treatment of patients with paroxysmal nocturnal hemoglobinuria","volume":"13","author":"Dmytrijuk","year":"2008","journal-title":"Oncologist"},{"key":"10.1016\/j.atherosclerosis.2014.03.004_bib17","doi-asserted-by":"crossref","first-page":"970","DOI":"10.4049\/jimmunol.159.2.970","article-title":"Endotoxin shock in antibody-deficient mice: unraveling the role of natural antibody and complement in the clearance of lipopolysaccharide","volume":"159","author":"Reid","year":"1997","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.atherosclerosis.2014.03.004_bib18","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1084\/jem.192.3.359","article-title":"A\u00a0hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in\u00a0vivo","volume":"192","author":"Taylor","year":"2000","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.atherosclerosis.2014.03.004_bib19","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1172\/JCI25208","article-title":"Targeted complement inhibition by C3d recognition ameliorates tissue injury without apparent increase in susceptibility to infection","volume":"115","author":"Atkinson","year":"2005","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2014.03.004_bib20","doi-asserted-by":"crossref","first-page":"5750","DOI":"10.4049\/jimmunol.174.9.5750","article-title":"Complement inhibitors targeted to the proximal tubule prevent injury in experimental nephrotic syndrome and demonstrate a key role for C5b-9","volume":"174","author":"He","year":"2005","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.atherosclerosis.2014.03.004_bib21","doi-asserted-by":"crossref","first-page":"7763","DOI":"10.4049\/jimmunol.175.11.7763","article-title":"In\u00a0vivo correction of complement regulatory protein deficiency with an inhibitor targeting the red blood cell membrane","volume":"175","author":"Spitzer","year":"2005","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.atherosclerosis.2014.03.004_bib22","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/j.1399-3062.2008.00329.x","article-title":"Humoral and cellular immune monitoring might be useful to identify liver transplant recipients at risk for development of infection","volume":"10","author":"Carbone","year":"2008","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.atherosclerosis.2014.03.004_bib23","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nm1419","article-title":"Generation of C5a in the absence of C3: a new complement activation pathway","volume":"12","author":"Huber-Lang","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.atherosclerosis.2014.03.004_bib24","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.2353\/ajpath.2006.060248","article-title":"Complement plays an important role in spinal cord injury and represents a therapeutic target for improving recovery following trauma","volume":"169","author":"Qiao","year":"2006","journal-title":"Am J Pathol"},{"key":"10.1016\/j.atherosclerosis.2014.03.004_bib25","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.4049\/jimmunol.180.2.1231","article-title":"Low-dose targeted complement inhibition protects against renal disease and other manifestations of autoimmune disease in MRL\/lpr mice","volume":"180","author":"Atkinson","year":"2008","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.atherosclerosis.2014.03.004_bib26","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.ajpath.2011.06.015","article-title":"CD55 deficiency protects against atherosclerosis in Apoe-deficient mice via C3a modulation of lipid metabolism","volume":"179","author":"Lewis","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1016\/j.atherosclerosis.2014.03.004_bib27","doi-asserted-by":"crossref","first-page":"8068","DOI":"10.4049\/jimmunol.181.11.8068","article-title":"A\u00a0novel targeted inhibitor of the alternative pathway of complement and its therapeutic application in ischemia\/reperfusion injury","volume":"181","author":"Huang","year":"2008","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.atherosclerosis.2014.03.004_bib28","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/art.30222","article-title":"The benefit of targeted and selective inhibition of the alternative complement pathway for modulating autoimmunity and renal disease in MRL\/lpr mice","volume":"63","author":"Sekine","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.atherosclerosis.2014.03.004_bib29","doi-asserted-by":"crossref","first-page":"7860","DOI":"10.4049\/jimmunol.179.11.7860","article-title":"A\u00a0complement C3 inhibitor specifically targeted to sites of complement activation effectively ameliorates collagen-induced arthritis in DBA\/1J mice","volume":"179","author":"Song","year":"2007","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.atherosclerosis.2014.03.004_bib30","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1161\/CIRCULATIONAHA.108.844589","article-title":"Complement regulator CD59 protects against angiotensin II-induced abdominal aortic aneurysms in mice","volume":"121","author":"Wu","year":"2010","journal-title":"Circulation"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002191501400149X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002191501400149X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:35:21Z","timestamp":1758155721000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002191501400149X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S002191501400149X"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2014.03.004","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted mouse complement inhibitor CR2-Crry protects against the development of atherosclerosis in mice","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2014.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}